Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blair Capitano

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing use of aminoglycosides in the critically illRhonda S Rea, Blair Capitano
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2003
Measurement of adherence to antiretroviral medicationsDavid L Paterson, Brian Potoski, Blair Capitano
Pharmacoeconomics|July 12, 2002
Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistanceJoseph L Kuti, Blair Capitano, David P Nicolau
Clinical Pharmacokinetics|February 8, 2011
Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipientsKelong Han, Robert Bies, Heather Johnson, et al.
Human Vaccines & Immunotherapeutics|November 22, 2018
Experience implementing a university-based mass immunization program in response to a meningococcal B outbreakBlair Capitano, Krista Dillon, Andre LeDuc, et al.
BMC Nephrology|May 24, 2017
Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysisPing Liu, Blair Capitano, Amy Stein, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 2013
Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysisLaura A Puzniak, Blair Capitano, Pinaki Biswas, et al.
Journal of the American Geriatrics Society|January 22, 2003
Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facilityBlair Capitano, O Alice Leshem, Charles H Nightingale, et al.
Surgical Infections|July 18, 2013
The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureusTherèse M Duane, Blair Capitano, Laura A Puzniak, et al.
International Journal of Antimicrobial Agents|December 9, 2003
Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia modelBlair Capitano, Dana Maglio, Mary Anne Banevicius, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing use of aminoglycosides in the critically illRhonda S Rea, Blair Capitano
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2003
Measurement of adherence to antiretroviral medicationsDavid L Paterson, Brian Potoski, Blair Capitano
Pharmacoeconomics|July 12, 2002
Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistanceJoseph L Kuti, Blair Capitano, David P Nicolau
Clinical Pharmacokinetics|February 8, 2011
Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipientsKelong Han, Robert Bies, Heather Johnson, et al.
Human Vaccines & Immunotherapeutics|November 22, 2018
Experience implementing a university-based mass immunization program in response to a meningococcal B outbreakBlair Capitano, Krista Dillon, Andre LeDuc, et al.
BMC Nephrology|May 24, 2017
Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysisPing Liu, Blair Capitano, Amy Stein, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 2013
Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysisLaura A Puzniak, Blair Capitano, Pinaki Biswas, et al.
Journal of the American Geriatrics Society|January 22, 2003
Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facilityBlair Capitano, O Alice Leshem, Charles H Nightingale, et al.
Surgical Infections|July 18, 2013
The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureusTherèse M Duane, Blair Capitano, Laura A Puzniak, et al.
International Journal of Antimicrobial Agents|December 9, 2003
Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia modelBlair Capitano, Dana Maglio, Mary Anne Banevicius, et al.
Pageof 3